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Abstract
Background: Physical activity is linked to breast cancer risk reduction in women, yet the mechanism remains
largely unknown. Possible causes for this association have been hypothesized to include change in
endogenous estrogen production, estrogen metabolism, circulating concentrations of peptide hormones and
growth factors, obesity, central adiposity, and immune function. Recent investigations in estrogen metabolism
in women have brought to light a new possibility for the association between physical activity and breast
cancer risk to be related to 2-hydroxyestrone metabolism increases with exercise, relative to 16α-
hydroxyestrone. This metabolite pathway has been studied as a mechanism for postmenopausal breast cancer
risk, but there are few studies concerning eumenorrheic, premenopausal women. The purpose of this
systematic review is to evaluate the most current research on this topic.
Methods: An exhaustive search of available medical literature concerning estrogen metabolism, breast cancer
risk, physical activity, and premenopausal females was conducted. The reviewed studies were limited to
randomized controlled trials, and prospective and retrospective cohort investigations.
Results: The six articles included in this review showed either non-significant changes in estrogen metabolism
to favor the anti-estrogenic 2-hydroxyestrone pathway, or no change at all in estrogen metabolism as a result of
physical activity. The only investigation reaching statistically significant results was a retrospective cohort
study relying on self-reports of physical activity. The six studies reviewed demonstrate vastly different
inclusion and exclusion criteria, as well as intervention protocols, causing comparison between studies to be
imprecise.
Conclusion: Current research has yet to identify the cause of the association between physical activity and
reduced breast cancer risk as related to changes in estrogen metabolism. Further investigation with large
randomized controlled trials with objectively measuring physical activity, utilizing standardized methods of
gathering and analyzing data is needed.
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Abstract   
 
Background:  Physical activity is linked to breast cancer risk reduction in women, yet the mechanism 
remains largely unknown. Possible causes for this association have been hypothesized to include 
change in endogenous estrogen production, estrogen metabolism, circulating concentrations of peptide 
hormones and growth factors, obesity, central adiposity, and immune function.  Recent investigations 
in estrogen metabolism in women have brought to light a new possibility for the association between 
physical activity and breast cancer risk to be related to 2-hydroxyestrone metabolism increases with 
exercise, relative to 16α-hydroxyestrone. This metabolite pathway has been studied as a mechanism for 
postmenopausal breast cancer risk, but there are few studies concerning eumenorrheic, premenopausal 
women. The purpose of this systematic review is to evaluate the most current research on this topic. 
Methods:  An exhaustive search of available medical literature concerning estrogen metabolism, 
breast cancer risk, physical activity, and premenopausal females was conducted. The reviewed studies 
were limited to randomized controlled trials, and prospective and retrospective cohort investigations.  
Results:  The six articles included in this review showed either non-significant changes in estrogen 
metabolism to favor the anti-estrogenic 2-hydroxyestrone pathway, or no change at all in estrogen 
metabolism as a result of physical activity. The only investigation reaching statistically significant 
results was a retrospective cohort study relying on self-reports of physical activity. The six studies 
reviewed demonstrate vastly different inclusion and exclusion criteria, as well as intervention 
protocols, causing comparison between studies to be imprecise.  
Conclusion:  Current research has yet to identify the cause of the association between physical activity 
and reduced breast cancer risk as related to changes in estrogen metabolism. Further investigation with 
large randomized controlled trials with objectively measuring physical activity, utilizing standardized 
methods of gathering and analyzing data is needed.  
Keywords:  Physical Activity, Breast Cancer, Estrogen Metabolism, Premenopausal Women 
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The Effects of Physical Exercise on Selected Markers of Estrogen Metabolism 
Linked to Breast Cancer Risk in Premenopausal Women 
 
BACKGROUND 
Physical activity is linked to breast cancer risk reduction in women, yet the mechanism remains 
largely unknown. Possible causes for this association have been hypothesized to include change in 
endogenous estrogen production, estrogen metabolism, circulating concentrations of peptide hormones 
and growth factors, obesity, central adiposity, and immune function.1,2  Other factors considered in the 
potential for breast cancer risk are body fat percentage, obesity, and body fat distribution, which might 
be influenced by physical activity.3 
The International Agency for Research on Cancer has identified body fat and physical 
inactivity as the most important avoidable cause of breast cancer.4 There is a great deal of evidence 
demonstrating this important link. 4-7  Friedenreich et al found a 30-40% decrease in breast cancer 
incidence among women who are physically active.8  Physical activity has been found to alter the level 
of sex steroids in both premenopausal and postmenopausal women.9-11  
Epidemiological studies show breast cancer risk is hormonally mediated.12-14 Friedenreich et al 
conducted investigations and concluded that association of exercise with breast cancer risk might be 
mediated by changing estrogens, estrogen metabolism, and metabolic factors such as reduction of 
excess body weight or body fat.1 Lifestyle factors such as diet,15,16 weight loss,17,18 smoking,11  body 
fat,3,14 and physical activity,3,17,19,20 can modify estrogen metabolism.  
 A cumulative lifetime exposure to estrogen has been associated with a higher breast cancer 
risk.2,8,10,13,21 Friedenreich et al hypothesized that physical activity might reduce breast cancer risk by 
lowering resting levels of estradiol and progesterone and increasing levels of sex hormone binding 
globulin.1,8  Estrogen metabolites, which result from the hydroxylation of the parent estrogens estradiol 
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and estrone, are implicated in the subtle link between estrogen and its proposed biological conditions 
like estrogen dependent cancers and osteoporosis.22,23  
 
Estrogen Metabolism 
Estrone and estradiol are synthesized in the body from the androgenic precursors 
andostenedione and testosterone.18 These hormones are synthesized in the liver by the cytochrome P-
450 enzyme aromatase.18 This reaction occurs in granulose cells, adipose cells, and placenta.18 These 
metabolites are further broken down by the body from inactive estrogen to the chemically active and 
unstable byproducts. The ovaries produce 17β-estradiol, which is the main source of estrogen for 
premenopausal women.24 The enzymes in mammary cells convert estradiol to estrone, which can be 
hydroxylated at positions 2 and 16α in their molecular structure.24  
Estrogen is metabolized by two main pathways. Endogenous estrogen in the body is converted 
to the more active estradiol, which is then oxidized to estrone.18 This estrone is hydroxylated to 2-
hydroxyestrone (2-OHE1) or 16α-hydroyxestrone (16-OHE1)25,26 through competitive pathways.2 
These pathways are irreversible, meaning that the hydroxylation cannot be reversed to produce the 
stable estrogen molecule once hydroxylation has occurred.18 The 2-hydroxylation pathway is three to 
four times greater than the 16α-hydroxlation pathway.25-27 There are other estrogen metabolites 
circulating in the body, including 4-hydroxyestrone and 2-methoxy-estradiol.27,28 These metabolites are 
still being researched, but there are much smaller levels of these metabolites in circulation.29   
The 16α-hydroxyestrone metabolite pathway for estrogen is considered estrogenic and may 
cause oxidative damage to DNA.30 This metabolite demonstrates estrogenic properties through 
covalent bonding with the estrogen receptor and stimulation of cell proliferation.31 These factors have 
been found to increase breast cancer risk.19,22 This metabolite is increased in breast cancer patients and 
women at high risk for breast cancer.32 Animal studies show this metabolite proliferates selectively in 
mouse mammary epithelial cells.25,32   
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In contrast, the 2-hydroxyestrone metabolism pathway is considered anti-estrogenic.2  2-OHE1 
is a weak estrogen because of rapid methylation, a rapid clearance rate, and weak binding affinity for 
the estrogen receptor, and the anti-proliferative effect on mammary cells.27 This pathway has a 
protective effect on estrogen metabolism and is associated with a reduced breast cancer risk, and a 
greater rate of breast cancer survival.5 Results from animal studies show clear evidence of protection 
against mammary tumors;23,32 it also decreases unscheduled DNA synthesis, and suppresses 
proliferation of human breast cancer cells.25,31 
  Friedenreich et al was the first to hypothesize that physical activity might reduce those 
estrogen metabolite levels that are implicated in breast cancer risk.1 However, the level of physical 
activity in many previous studies has not been significant enough to decrease the absolute amounts of 
circulating estrogens.33 Snow et al found changes in concentrations of sex steroids among elite athletes 
who experienced menstrual dysfunction, but further studies failed to replicate this in normally active 
young women.17,33 From there, follow-up investigations tended to include exercise matched with 
concurrent calorie restriction because of the hypothesis that exercise alone is not enough to change the 
central control of the reproductive axis and produce a hypothalamic/pituitary response.33  
Another theory that sparked further studies was the potential for a change in the metabolite 
ratio to favor the anti-estrogenic 2-hydroxyestrone pathway, even if the total concentration of the 
estrogen metabolites remained unchanged.33  Previous research shows intense exercise increases 2-
OHE1 formation but there is little research on less extreme exercise and its effect on estrogen 
metabolism.3  Previous measures of estrogen metabolites relied on radiolabled tracers and gas 
chromatography-mass spectroscopy.18 Newer methods of measuring estrogen metabolite ratios through 
simple urine samples have lead to increases in research potential.  
The 2:16 estrogen metabolite ratio may also be influenced by diet, physical activity levels, and 
smoking.11,17 Atkinson et al found that changes in intra-abdominal fat were associated with changes in 
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the 2:16 estrogen metabolite ratio.20  Interest in the newest idea that the 2:16 estrogen metabolite ratio 
might affect the breast cancer risk of women sparked further breast cancer prevention research.  
 
Limitations of Current Research 
Current research is conflicting in regards to the potential effect of this estrogen metabolite ratio 
and the potential for breast cancer risk reduction related to physical activity. Some studies show a 
positive link,15,16,22,34 but not all,12,26 and most prospective cohort investigations show only a non-
significant risk reduction.30  Many investigations are limited to only elite athletes.353617,37 Furthermore, 
many investigations include participants with menstrual dysfunction related to physical activity, use 
only cross-sectional analyses, or rely on only self-reports of physical activity without conducting a 
controlled intervention.2 The reduction in sex steroid hormones related to physical activity might be 
confounded by or related to menstrual dysfunction.17,37  
 
Purpose of the Study 
The purpose of this investigation was to conduct a systematic literature review to determine the 
effects of physical activity on estrogen metabolite ratios in premenopausal women. Specifically, this 
investigation was conducted to determine if the 2:16 estrogen metabolite ratio is increased through 
physical activity to favor the anti-estrogenic estrogen metabolite associated with reduced breast cancer 
risk.  
 
METHODS 
Search Protocol 
 A systematic review of the current medical literature was conducted using four main literature 
review databases. The databases included in the search were MEDLINE, CINAHL, All EBM Reviews, 
and EPPI-Centre Database of Health Promotion Research (Bibliomap). Search terms were mapped to 
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established, standardized medical subject headings (MeSH) when made available by the search engine. 
For example, when searching the MEDLINE database, search terms were mapped to the MeSH terms 
“breast neoplasms,” “estrogens,” “exercise,” and “premenopause.” Terms used in searching all 
databases included “physical activity,” “2-hydroxyestrone,” “biological markers,” “estrogen 
metabolism,” “estrogens,” “hydroxyestrones,” and “estrogens, catechol.” Only randomized controlled 
trials, and prospective and retrospective cohort studies were included in this review.  
 All articles referenced in this systematic literature review were critically appraised and ranked 
on validity measures using a validity measure scoring system relevant to this subject matter (See 
Appendix). The summary of the critical appraisals of the included articles is listed in Table 1.  
 
Inclusion and Exclusion Criteria 
 This search was limited to randomized controlled trials, and prospective and retrospective 
cohort studies that were conducted on a specific population and measuring explicit outcomes. Case-
control studies have been excluded. The population considered for this review included premenopausal 
women who did not have a current diagnosis or history of breast cancer. The outcomes of the included 
studies were measured as a change in the ratio of estrogen metabolites linked to breast cancer risk.  
Specifically, only studies that measured the ratio of 2-hydroxyestrone to 16α-hydroxyestrone were 
included in this systematic review. Studies were excluded if the population included only 
postmenopausal women, if the population had current incidence or history of breast cancer, and if the 
outcomes of the studies were not measured as a change in the estrogen metabolite ratio. Articles were 
included in the analysis if the outcomes measured also included various estrogen metabolites, such as 
4-hydroxycatecholestrone, or if other variables such as BMI or body composition were included in 
analysis. However, these other factors were not analyzed for the purposes of this systematic review.  
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RESULTS  
 A total of 39 records were identified through database searching according to medical subject 
headings. A thorough search through the references of identified articles revealed 104 additional 
articles for review. After duplicates were removed, 49 articles were screened for inclusion criteria, and 
31 were removed because they were not randomized controlled trials or cohort studies. The full-text 
articles meeting this criteria were assessed for eligibility and 24 were excluded because the subjects 
were either postmenopausal, had breast cancer diagnoses, or the results were not measured as a change 
in the estrogen metabolite ratio. A total of six articles meeting the inclusion criteria were analyzed for 
the purposes of this systematic literature review. Only two randomized controlled trials concerning the 
population in question were discovered, and the remaining studies included in the review are cohort 
studies. Please see Table 2 for complete information regarding specific inclusion and exclusion criteria 
of the selected studies.  
 
Campbell et al 2007 
 A randomized controlled trial conducted by Campbell et al, 200730 attempted to determine the 
effects of a 12-week aerobic exercise training program on estrogen metabolites in sedentary or 
recreationally active premenopausal women. Caucasian females who were sedentary or recreationally 
active were included in this study. Recreational activity levels were defined as less than 20 minutes per 
day, three times per week in the past six months, with no formal aerobic training during the past year. 
Fitness levels of participants were measured using standardized VO2max measurements, and 
participants with measurements greater than 40 mL/kg/min were excluded. Other inclusion criteria 
were age between 20-35 years, regular menstrual cycles, and body mass index (BMI) 18-29.9kg/m2. 
Regular menstrual cycles for the purposes of this investigation consisted of cycle length of 24-36 days, 
with menstrual cycles for at least ten out of the past twelve months.30  
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Participants in this study were excluded if they had used hormonal contraception or tobacco 
products in the past 12 months. Participants were also excluded from the study if they were vegetarian, 
if they had any metabolic health conditions such as thyroid disorders, diabetes, or liver disorders. 
Finally, participants were excluded if they were currently taking any medications that can interfere 
with hormonal pathways such as antidepressants or antibiotics, or if they had any pre-existing 
musculoskeletal conditions which prevented them from participating in an exercise program.30  
 Initial measures of height, weight, BMI, and waist-to-hip ratio were completed for each 
individual. Each participant filled out a three day diet log prior to participation, and calculations were 
made to ensure there was no baseline difference in amount of cruciferous vegetables or soy products 
linked to alterations in estrogen metabolism.11 Additionally, aerobic fitness was measured with a 
VO2max test using an incremental graded exercise stationary bike, with the criteria for reaching 
VO2max set as a plateau in oxygen consumption with increasing power output and/or respiratory 
exchange ratio of >1.1.30  
 The 17 participants randomized to the intervention group participated in a 12 week graded and 
individualized exercise program. Participants attended supervised exercise sessions 3-4 days per week. 
Exercise intensity was modified based on a six week repeat VO2max test. Meanwhile, the 15 
participants randomly assigned to the control group were advised to maintain their normal level of 
activity and dietary intake. After the conclusion of the clinical trial the participants in the control group 
were given individualized guidance for starting their own exercise program, along with access to the 
fitness facility for four weeks.30  
 First morning urine samples were collected for all individuals in this investigation during the 
luteal phase of their menstrual cycles, standardized at day 20-22 since the self-reported first day of 
their last menstrual period. First morning fasting saliva samples were collected on days 19-22 of the 
menstrual cycles of all participants to confirm mid-luteal progesterone surge. 30 
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Fourteen out of seventeen members of the intervention group completed at least 80% of the 
supervised exercise sessions. The exercise group increased their aerobic capacity measured by 
VO2max, while the control group decreased their measured aerobic fitness (+4.6mL/kg/min, and -1.0 
mL/kg/min, respectively). There was no significant change found in either group for body weight, 
BMI, or waist –to-hip ratio (WHR). The exercise group lost a mean of 1.2kg fat mass and gained a 
mean of 0.9kg lean mass. The baseline 2:16 ratio was significantly associated with percentage of body 
fat. Those with the highest percentage of body fat had significantly lower 2:16 ratios, meaning the 
concentration of 2-hydroxyestrone was relatively low in comparison to those individuals with a lower 
percentage of body fat.  There was no change in the 2:16 ratio after intervention among the exercise 
group. There was no change in 2:16 ratio from baseline in either group. The improvement in aerobic 
fitness capacity did improve the 2:16 ratio. There was a positive association that approached 
significance between the percentage of lean body mass and 2:16 ratio.30 
 The end result of this investigation  was that 12 weeks of aerobic exercise training was great 
enough to bring about an  improvement in VO2max and modest body composition changes, yet still 
had no significant effects on estrogen metabolism enough to alter the ratio of 2-OHE1 to 16α-OHE1.  
This study concluded that potentially exercise and physical activity interventions may not have 
significant effects on estrogen metabolism in premenopausal women.30  
 
Pasagian-Macaulay et al 
 Pasagian-Macaulay et al18 endeavored to assess the reliability of measuring estrogen 
metabolites in urine, and to measure the relationship of body weight, dietary fat and exercise to urinary 
estrogen metabolite ratios in premenopausal women. Participants in this study were 179 
premenopausal women aged 44-50. The participants were pooled from the Women’s Healthy Lifestyle 
Project (WHLP)18. Participants were not currently taking any hormonal replacement or contraceptives. 
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All participants had a BMI of 20-34 kg/m2 and were not enrolled in any weight reduction programs 
during the previous four months.18 
 Participants were excluded from the investigation if they had experienced two months of 
amenorrhea during the previous six months. Potential participants were also excluded if they had been 
hospitalized at a psychiatric facility within the previous year, or had a previous history of cancer within 
the past five years. No participants were accepted if they were currently using antihypertensive 
medications, had an elevated LDL or total cholesterol, or had an elevated fasting blood glucose reading 
above 140. Additionally, participants were excluded if they drank more than five alcoholic beverages 
per day, or if they had had a hysterectomy or bilateral oophorectomy. 18 
 A standardized Paffenberger physical activity questionnaire was given to all participants at the 
start of the trial to assess current leisure physical activity levels.  The participants randomly assigned to 
the intervention group attended a 20 week program lead by trained nutritional and behavioral 
interventionists. The goals of the program were to reduce fat intake to less than 25% of total calories, 
reduce saturated fat intake to less than seven percent of total calories, reduce cholesterol intake to less 
than 100mg per day, and to increase moderate physical activity in the form of walking to expend about 
20% of the daily total of calories. The intervention group attended 15 sessions with training on diet and 
exercise to achieve modest weight loss. The weight loss goals for those with a normal BMI (<24.44) 
were set at five pounds total over the six month time period of this investigation. Those with a BMI 
24.45-26.44 were assigned a ten pound weight loss goal, and those with a BMI higher than 26.44 were 
given a 15 pound weight loss goal. All participants in the intervention group followed a 1300 or 1500 
calorie per day meal plan for four weeks, and then followed their own self-modified diet with dietary 
logs for the remainder of the intervention.18 
 The participants in the intervention group were all encouraged to increase physical activity 
starting at week three of the intervention. Participants were given instructions to walk ten miles per 
week over three to five days, with a goal of expending 1500 calories per week. Those participants who 
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already were expending 1500 calories per week through modest activity were encouraged to maintain 
their current level of physical activity. All physical activity was self-regulated and self-reported. There 
was no formal supervision of the exercise portion of the intervention.18 
 Both groups were evaluated in the clinic at baseline and at six months. First morning urine 
samples were collected individually after a ten hour fasting period at baseline and at six months. 
Vitamin C was added to the samples as a preservative. All samples were stored on dry ice for 48 hours 
while shipping to the testing facility. Subjects were separated into three tertiles based on their estrogen 
metabolite ratios at baseline measurements. The low estrogen metabolite ratios were 0.5-1.75, the 
medium metabolite ratios were 1.76-2.47, and the high estrogen metabolite ratios were greater than 
2.47. There was no attempt made by the authors of this investigation to standardize the urine samples 
according to the phase of the menstrual cycle.18 
 There was a significant increase in the estrogen metabolite ratio 2:16 for both intervention and 
control groups, but no statistically significant difference between both groups for change in ratio. That 
is, both groups experienced an increase in ratio of estrogen metabolites, but there was no greater 
change in the exercise intervention group as compared to the control group. There was no significant 
relationship between any of the baseline risk factors and the baseline 2:16 ratio in either group.  The 
intervention group improved their physical fitness, as measured by the standards set by the authors of 
this investigation. The intervention group lost an average of ten pounds and increased their total 
exercise amount by 400 calories per week. The increases in weight, BMI, and waist-to-hip ratio in the 
control group were all significantly correlated with the changes in the 2:16 ratio, but this relationship 
was not found in the intervention group.18 
The authors of this study hypothesized that perhaps their subjects lost weight but didn’t 
sufficiently deplete fat stores to increase the 2-hydroxylation pathway of estrogen. The authors 
suggested that perhaps only a combination of significant increase in exercise and decrease in total 
calories and fat will alter estrogen metabolism enough to result in a positive change in the 2:16 
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estrogen metabolite ratio.  Another theory brought forth by the authors of this investigation was that 
this ratio might be more determined by genetics than the authors had originally hypothesized.18 
 There were three hypotheses produced by the authors of this study to determine the results they 
found. They hypothesized that the ratio of specific metabolites might have less relation to breast cancer 
risk than the total production of estrogen. Second, the metabolism of estrogen might be more 
determined by environmental factors, such as phytoestrogens in plants, than by level of physical 
activity. Finally, the metabolites of estrogen that are established risk factors for breast cancer might be 
more determined by genetics and environmental factors than originally hypothesized by the authors of 
the current study. The authors rationalized that postmenopausal breast cancer risk is higher because 
postmenopausal estrogen is primarily metabolized from the aromatization of andostenedione in fat 
tissue, and is no longer produced from the ovaries. Due to this factor, the authors reasoned that obesity 
is a significant determinant of estrogen levels in postmenopausal women, rather than in premenopausal 
women.18 
The weight difference between groups in this study was significant, but did not produce 
changes in 2-hydroxylation of estrogen. The authors suggested that postmenopausal women metabolize 
estrogen more along the 16α-hydroxylation pathway, so a more estrogenic shift in postmenopausal 
women can perhaps reflect a greater effect from physical activity levels than in pre-menopausal 
women, who already metabolize estrogen primarily along the 2-hydroxylation estrogen pathway.18 
 
Westerlind et al 
 Westerlind et al33 sought to discover whether physical activity and/or energy deficiency 
increased the 2:16 ratio, and whether or not this is a factor in the reduction in breast cancer risk 
correlated with physical activity. Also, the authors of this clinical trial attempted to determine the 
effect of moderately intense exercise training combined with calorie restriction on 2:16 ratio of 
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estrogen metabolism. The measurement of an increase in physical activity was determined to be the 
loss of body weight and body fat, and an increase in VO2max.33  
 The authors of this study set specific inclusion criteria for participants. All participants had to 
be free of any serious medical conditions, without current depression or eating disorders. Participants 
were between the ages of 25 and 40, and weighed 50-90 kg.  Members of this study were required to 
have a body fat percentage between 15-45%, and BMI 18-35. Participants were non-smokers, who 
were not currently taking any anti-depressants or antibiotics, had no significant weight changes during 
the past 12 months, and exercised less than one hour per week. All participants had to have a 
gynecological age of at least 13 years, were not using any hormonal contraception during the past six 
months, had regular menstrual cycles, and were free of any musculoskeletal conditions that might limit 
participation in any physical exercise.33 
 A total of 31 subjects began a four month intervention of moderate aerobic exercise and calorie 
restriction. Twenty-four participants completed the entire study. Those participants who dropped out of 
the investigation were those in the group who had significantly higher percentages of body fat and 
BMIs. Participants were measured for one complete baseline menstrual cycle, and four subsequent 
menstrual cycles during the intervention phase. All subjects attended supervised informational sessions 
designed to give participants the tools to increase their physical energy expenditure by twenty percent. 
In addition, all participants were encouraged to decrease total caloric intake by 20-35%. Daily 
menstrual records were kept by each participant, with daily urine collections to verify hormone levels. 
Urine was analyzed for estrogen metabolites and 2:16 ratios during the mid-folicular and mid-luteal 
cycles of each participant individually.33 
 Baseline depression and eating disorder inventories were taken on all participants, and subjects 
were compared from baseline complete blood counts, chemistries, and endocrine screening.  Diet 
records were kept for three to four days and submitted by all subjects. Baseline aerobic fitness capacity 
was measured using VO2max recordings on a standardized stationary bicycle. Body composition was 
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measured with hydrostatic weighing. Menstrual status of each participant was measured at baseline, 
and then measured daily during the control menstrual cycle, and each subsequent intervention cycle.33 
 Caloric restriction was performed by each subject individually. Participants kept self-reported 
diet logs and met with a dietician every two weeks. Diet was adjusted individually if there was no 
recorded weight loss, and measurements of cruciferous vegetable and soy intake were monitored to 
ensure there was no significant difference among participants.33 
 All participants attended supervised workout sessions four times per week with personal 
trainers. Each workout lasted 40-90 minutes, and workouts were personalized with the end goal of 
achieving 60-90% of maximal heart rate. There was an average of 96% attendance of the exercise 
sessions, with an average of 3.6 workouts logged by participants per week. Caloric expenditure was 
individually measured and standardized to achieve 20% of each participant’s caloric intake. Fist void 
urine samples were brought in daily on ice from each participant. Each urine sample was preserved 
with boric acid, refrigerated for no more than four hours before processing, and shipped on dry ice to 
the standardized testing facility. The 2:16 ratio of estrogen metabolites was normalized to creatinine 
concentration in the urine samples.33 
 The baseline measurement of 2-hydroxyestrone metabolites was inversely correlated with 
baseline BMI. Over the course of the study, significant changes in weight, BMI, body fat, VO2max, 
and caloric intake were achieved, but there was no statistically significant change in lean body mass 
percentage. There was no difference in the ratio of 2-hydroxyestrone metabolism to 16α-
hydroxyestrone metabolism between the follicular and luteal phases, although the total concentrations 
of both estrogen metabolites were found to be significantly higher during the luteal phases of each 
participant. The only statistically significant change in estrogen metabolite concentration found, was an 
increase in 16α-hydroxyestrone metabolism during the luteal phase, and a nearly significant increase in 
2-hydroyestrone metabolite concentration also during the luteal phase.33 
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 The authors of this investigation found an association between the change in the ratio of 2:16 
metabolism of estrogen and the baseline ratio of 2:16. This development led the authors to hypothesize 
that some women are considered responders, while others are non-responders. That is, some women 
respond to exercise interventions with an increase in the 2:16 ratio of estrogen metabolism, while other 
women do not. Subjects were divided into Tertiles based on this theory. Tertile 1 had an average 
baseline ratio of 0.91. Subjects in Tertile 2 had an average 2:16 ratio of 1.97, and participants in Tertile 
3 had the highest average baseline ratio of 2.95. There was no significant difference between Tertiles 
as far as weight, fat, fitness, percent fat loss, calories consumed, or menstrual cycle length. The only 
significant difference found was that exercise intensity was lower Tertile 2. The women with the 
lowest baseline ratio of 2:16 metabolism experienced the greatest increase in 2:16 ratio during 
intervention. This higher increase was found in both categories of percentage increase, and absolute 
increase in ratio.33 
 The authors of this investigation believed that it was unlikely that exercise intensity was 
associated with the change in 2:16 ratio. Since the participants were involved in exercise, calorie 
restriction, and weight loss simultaneously, it is impossible to determine the specific cause of the 
changes in metabolite ratios. Those participants in the lowest Tertile of baseline ratio did not lose more 
weight or fat or become more aerobically fit. Therefore the authors hypothesized that the favorable 
change in estrogen metabolites associated with a decrease in breast cancer risk is not determined by 
initial body fat or body weight, or by the magnitude of change in body composition from exercise. 
Rather, the change might be most determined by the woman’s initial estrogen-metabolism profile. The 
investigators developed the theory that women with a higher initial ratio of 2:16 metabolism might 
already be at a lower risk for developing breast cancer. Accordingly, these women might not 
experience a significant change in estrogen metabolite concentration due to physical activity. The 
authors suggested that estrogen metabolite profiles of women could potentially be used to identify 
women at higher risk for breast cancer if they have lower ratios of 2:16 metabolism of estrogen, and 
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these particular women could be identified as a population who might benefit most from targeted 
intervention designed to increase physical activity in order to increase the anti-estrogenic biochemical  
metabolism.33  
 
Schmitz et al 
 Schmitz et al38 investigated the effects of 15 weeks of aerobic exercise training on oxidative 
stress, estrogen metabolites, and body composition in 15 premenopausal, eumenorrheic women.  All 
women included in this study were between 18-25 years old and experienced regular menstrual cycles. 
All participants were nulliparous with intact ovaries and uterus. The participants were sedentary, which 
was defined as less than two moderate intensity exercise sessions per week for the past six months. 
Participants had BMI 18-40 and consumed less than seven alcoholic beverages per week. Participants 
were excluded if they had used hormonal contraception within the past year or were pregnant in the 
past six months. Participants were also excluded if they had any gynecological disorders such as 
fibroids, endometriosis, or polycystic ovarian syndrome. Additionally, women were excluded from the 
study if they had uncontrolled hypertension, had used tobacco products during the previous month, or 
had any physical conditions limiting their participation in an exercise intervention program.38 
 All participants in this investigation had clinic visits at baseline and post-intervention during 
the follicular phase of their menstrual cycle. The clinic visits all took place after a 12 hour fast, and at 
least 48 hours after completion of any exercise. There was a 54% dropout rate during this 
investigation. Only 15 participants of 28 completed this study.38 
 Baseline body composition was measured with dual energy x-ray absorptiometry, and baseline 
fitness was assessed by maximum heart rate, based on participants reaching 80% of their age-based 
calculated maximum heart rate. All participants also completed baseline Diet History Questionnaires to 
measure their dietary intake at the onset of the investigation. First void urine samples were collected on 
three consecutive days. All samples were preserved with sodium azide and normalized to creatinine 
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concentration. All subjects started exercise intervention on the eleventh day of their self-reported 
menstrual cycle and stopped on the fifth day of their menstrual cycle 3-4 cycles later.38 
 All participants attended five weekly training sessions that included 30 minutes of physical 
activity with a warm up and cool down. The goal for all participants was to achieve 70-85% of their 
maximum heart rate, with heart rate goals increased weekly. Workouts were supervised once per week, 
and the remainder of physical exercise was self-recorded.38 
 There was an 87.5% adherence rate to the exercise program, with a target level of heart rate 
achieved 95.3% of the time. There was no statistically significant change in absolute concentrations of 
2-hydroxyestrone or 16α-hydroxyestrone, or in the 2:16 ratio from baseline to intervention. A marker 
of lipid peroxidation, F2-isoprostanes, declined slightly from the course of baseline through 
intervention. There were also significant decreases in body weight, BMI and body fat percentage. This 
caused the investigators to believe that some of the radicals that lead to the peroxidation of lipids may 
damage DNA. They theorized that exercise has the potential to significantly alter the formation of free 
radicals and lipid peroxidation, and this may be influential in future efforts towards cancer prevention.  
The authors concluded that exercise decreases the potential for developing certain types of 
cancers, but not because of a change in 2:16 ratio of estrogen metabolism. The free radicals associated 
with lipid peroxidation were thought to be an area for potential future research in the field of cancer 
prevention. The authors of this article theorized that a woman needs enough of an energy deficit to 
cause weight loss and produce anovulation in order to change estrogen metabolism, and those results 
were not found in this study. The researchers suggested future research should concentrate on luteal 
phase estrogen metabolism, as this phase measured the highest total estrogen concentrations. 38 
 
Bentz et al 
 Bentz et al34 sought to determine whether higher levels of physical activity might be correlated 
with higher levels of 2-hydroxyestrone metabolites and higher 2:16 ratios. The authors also desired to 
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determine if the 2:16 estrogen metabolite ratio might be a biomarker for breast cancer risk reduction 
that can then be incorporated into exercise programs based on a specific intensity and duration of 
exercise.34 
 Seventy-seven women in this study met the specific inclusion criteria for participation. All 
volunteers were eumenorrheic over the previous year, were non-smokers, were not taking hormonal 
contraceptives, and had a BMI 18-30. Women were excluded from this study if they were vegetarian, 
pregnant or lactating, or had any metabolic disorders such as thyroid imbalance or diabetes. 
Additionally, all African Americans were excluded from this study because of the prevalence for 
polymorphisms in the gene that produces the 2-hydroxylating enzyme.34 
 Urine samples were collected during the self-reported luteal phase of participants. Diet was 
self-recorded on two weekdays and one weekend day for two weeks prior to specimen collection. 
Physical activity logs were self-maintained by participants for two weeks prior to urine sampling. 
Physical activity reported on the logs included household work, leisure activity, occupational activity, 
and sport-related physical activity. All reports of activity were analyzed using Borg’s modified ratings 
of perceived exertion (RPE) to calculate standardized metabolic equivalent (MET) values and total 
MET hours of physical activity per week.34 
 First morning urine samples were preserved with ascorbic acid, refrigerated for no more than 
four hours prior to handling, transported on ice to the standardized treatment facility, and normalized 
to each individual’s urine creatinine concentration. Participants were separated into overweight (BMI 
greater than 25) and normal weight (BMI 25 or less) groups to examine the relationship between 
physical activity and to rule out BMI as a possible confounding factor. Also, amounts of brassica 
vegetable and supplement intake were measured to rule out differences between groups. No significant 
differences between groups were noted.34 
The amount of self-reported MET hours per day ranged from zero to 14.31 for all participants. 
Significant differences were found between concentrations of 2-hydroxyestrone and 2:16 ratios related 
25 
 
to MET hours of physical activity. Age and BMI were statistically controlled for, with no effect of 
possible peri-menopause found. The normal BMI group did not show significant relationships between 
MET hours of physical activity and estrogen metabolites when analyzed based on BMI alone. The 
overweight group did demonstrate a significant relationship between MET hours of physical activity 
and concentrations of both 2-hydroxyestrone and 2:16 ratio of metabolites. When participants in the 
overweight BMI group were studied individually, 11 out of 19 identified themselves as highly 
competitive and reported exercising 5-7 days per week. The authors of this investigation concluded 
that stratifying participants based on BMI alone is not an accurate measure of body composition in 
athletes. The participants in the higher BMI group in this study most likely did not have high body fat 
percentages, since the majority of them were competitive athletes.34 
 No relationship was found between physical activity and BMI. There was also no significant 
relationship between 16α-hydroxyestrone concentration levels and levels of self-reported physical 
activity. The authors of this investigation separated participants into quartiles based on reported MET 
hours per week of physical activity. There was no statistically significant difference between quartiles 
for 2:16 estrogen metabolite ratio, but the difference between groups approached significance, with the 
most physically active group measured to have the highest 2:16 metabolite ratio. The frequency of 
physical activity was significantly different between the highest and lowest quartiles, along with the 
baseline 2:16 ratio and baseline 2-hydroxyestrone concentration.34 
 At the conclusion of this investigation, authors determined that sex hormones might be 
modulated by physical activity to favor the weak estrogen, 2-hydroxyesterone. This change in 
metabolism might be a potential mechanism for the breast cancer risk reduction correlated to physical 
activity. In light of evidence that body fat percentage is correlated with estrogen metabolism and the 
findings of an overweight BMI group, which turned out to be comprised of mostly athletes, the authors 
concluded that body fat percentage might indeed be a confounding factor in the measurement of 2-
hyrdoxylation of estrogens. Women in this study who were most active had the highest baseline 2:16 
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ratio. The authors concluded that exercise intensity beyond moderate might be required in order to 
significantly change estrogen metabolism.34 
 
Campbell et al 2005 
 Campbell et al, 20052 investigated the association between aerobic fitness levels and 2:16 
estrogen metabolite ratio, and total concentrations of each estrogen metabolite in premenopausal 
women. Their hypothesis was that premenopausal women with higher aerobic fitness levels would 
have higher concentrations of the anti-estrogenic 2-hydroxyestrone, and lower concentrations of the 
estrogenic 16α-hyrdoxyestrone, and therefore a higher 2:16 ratio.2 
Caucasian women aged 20-42 years old were included in this study. Participants were required 
to have regular menses and a BMI 18-24. Volunteers were excluded from participation if they were 
smokers, had taken hormonal contraception in the previous six months, if they were vegetarian, had 
any endocrine disorders, were currently taking antibiotics or antidepressants, or had any physical 
conditions limiting exercise participation.2 
This investigation was carried out in an extreme group split design. The participants all filled 
out Godin Leisure Time Exercise Questionnaires21 and were separated into groups on either end of the 
physical activity spectrum. Those who reported strenuous exercise 3-5 days per week for the previous 
six months were selected for one group, and those who reported little or no physical activity were 
selected for the other group. All volunteers also completed a PAR-Q Physical Activity Readiness 
Questionnaire, and then were subjected to a graded exercise test with indirect calimetry using VO2max 
to determine baseline physical fitness level. The high fitness group had VO2max scores greater than 
48ml/kg/min, while those in the average fitness group had scores of less than 40ml/kg/min. Baseline 
measures of the sum of skin folds were substituted for the percentage of body fat, and the BMI of each 
participant was also measured at the start of the trial. The diet of each individual was assessed over the 
previous 12 months using a standardized Diet History Questionaire.21,2 
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Two first morning urine samples were collected from each participant after a ten hour fast 
between days 4-6 and 20-22 of the same menstrual cycle of each woman. No physical activity was 
allowed 24 hours prior to urine sampling. The urine samples were stored on ice and processed within 
four hours, with ascorbic acid added as a preservative. The menstrual status of each individual was 
determined from saliva samples collected from day 12 forward in the menstrual cycle.2 
A total of 13 out of the 18 members in the average fitness group completed the study, while 17 
out of the original 18 members of the high fitness group completed the study. The members of the high 
fitness group reported about 368 minutes of physical activity per week, compared to about 64 average 
minutes of physical activity reported from the average fitness group. There was no significant 
difference between groups in categories of age, body weight or BMI. The average fitness group had a 
higher percentage of body fat, measured by sum of skin folds. There was no significant difference 
found between the groups as far as the total concentrations of either estrogen metabolite, or the 2:16 
ratio. The high fitness group showed a trend towards higher luteal 2:16 ratio, although no results were 
statistically significant. The high fitness group consumed more calories, carbohydrates, fiber and 
vegetables than the average fitness group; however, these differences were not found to be statistically 
relevant to the changes in the 2:16 ratios. A higher BMI and body fat percentage was associated with a 
lower 2-hydroxyestrone concentration and a lower 2:16 ratio in further analysis after the conclusion of 
the trial. Also, the total concentration of the more estrogenic 16α-hydroxyestrone was found to be 
higher in those with higher BMI and percent body fat.2 
The authors of this investigation theorized the potential reasons for the non-significant changes 
in estrogen metabolite ratios. The thresholds set to evaluate physical fitness using VO2max scores 
might not have been accurate.  The investigators suggested that estrogen metabolism changes due to 
physical activity might only occur when moving from low to average fitness, rather than from average 
to high fitness. They theorized that physical activity might affect estrogen metabolism, but perhaps not 
because of aerobic fitness, which was the measure set by this study. Physical activity might have a 
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greater effect on sex steroids, circulating growth factors, or binding proteins than on the estrogen 
metabolite ratio. Alternatively, physical activity might instead affect body composition, immune 
function, or antioxidant defenses, which might alter breast cancer risk by changing estrogen 
metabolism. The authors concluded that these changes might not necessarily increase aerobic fitness 
levels.2  
 
DISCUSSION 
 There was a great deal of variability across all six studies included in this review. One large 
difference between the articles was the inclusion and exclusion criteria. Some investigations sampled a 
very specific population based on extensive inclusion and exclusion criteria,30,2,33 while other studies 
were not as specific.18,38 Some studies included only athletic or moderately athletic individuals,18 some 
looked at only sedentary individuals,30,38 and some looked at both extremes.34 As Westerlind et al33 
discovered, the baseline 2:16 ratios were important in determining the potential for change in those 
estrogen metabolites according to physical activity intervention. If there was a wide variation in 
baseline levels of physical activity between individuals, groups, and studies, then the results gathered 
from these investigations might be suspect. This difference in baseline characteristics of the 
populations under investigation might affect the results.  
 There were specific limitations in each study included in this review that warrant further 
discussion. The differences in populations investigated, interventions, and statistical analysis methods 
make comparisons between studies difficult.  Many studies were limited by small sample size and lack 
of a control group for comparison.33,38,34,2 Also, there was little standardization between studies for 
menstrual cycle. Some investigations measured hormonal changes to determine stage in menstrual 
cycle,30,2,33 while others used only self reported measures,38,34 and others did not attempt to control for 
menstrual stage at all.18 Some studies prior to this review used older methods of estrogen metabolism 
measurement. All studies included in this review used newer solid-phase enzyme immunoassay to 
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determine estrogen metabolite concentrations. Finally, there were variations among studies in baseline 
physical measurements. Some investigations measured body composition with hydrostatic weighing or 
dual energy x-ray absorptiometry technology,33,38 while others simply used BMI as a substitute for 
measurement of body composition.30,2,34 As Bentz et al34 determined, BMI is not a valid measure of 
body composition in a lean athletic population. Table 3 demonstrates the specific limitations of each 
investigation based on selected criteria.  
 
Type of Investigation and Absence of Control Group 
 Of the six studies included in this review, only two can be classified as randomized controlled 
trials.30,18 The remaining four investigations were classified as cohort or crossover studies, meaning 
that the same participants were measured at baseline and after intervention and served as their own 
controls.33,38,34,2 Campbell et al, 200730 and Pasagian-Macaulay et al18 were the only authors to include 
a control group in their investigations, and they were both limited by the fact that they did not have a 
similar intervention for the control group. Campbell et al, 200730 advised the control group to continue 
with their regular diet and exercise routines, which might introduce a bias, as the samples were not 
blinded to their assigned treatment group. Pasagian-Macaulay et al18 failed to mention the control 
group in their investigation, which leads the reader to assume there was no planned placebo 
intervention for the control group. The remaining authors failed to use a control group at all, although 
Campbell et al, 20052 divided the participants into a highly physically fit group and an average 
physically fit group for comparison.  
 An additional factor in some but not all investigations was the addition of dietary changes to 
physical activity level changes. There were no dietary changes reported by Campbell et al, 200730 or 
Bentz et al34, while Pasagian-Macaulay et al18 and Westerlind et al33 included dietary restriction as a 
vital component of their interventions. Further, Bentz et al34 and Campbell et al, 20052 included self-
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reported dietary logs of participants in their calculations to control for possible confounding factors, 
while the remaining authors did not.18,30,33,38  
 
Baseline Characteristics 
 One interesting finding by Pasagian-Macaulay et al18 is the association between baseline 2:16 
ratio and the percent of change of that ratio based on physical activity. This study was the only one of 
the six included in this review that recorded baseline 2:16 ratio for the purposes of comparison to 
outcomes. It would be very interesting compare the baseline 2:16 ratios in relation to outcome ratios of 
each investigation, if this data had been included in the other studies.  
Some studies limited the amount of baseline physical activity, while others did not. This 
potential difference in baseline physical fitness might affect results. In fact, this baseline difference 
was used to separate participants into high and average fitness groups in order to compare retrospective 
reports of physical activity in the study conducted by Campbell et al, 2005.2 In this investigation, 
participants were separated into two groups based on self-reported physical activity of 3-5 days per 
week and VO2max scores greater than 48, or no reported physical activity and VO2max scores less 
than 40.2  The more recent study by Campbell et al, 200730 limited physical activities to less than 20 
minutes per day, three times per week, with VO2 max scores less than 40. Westerlind et al33 limited 
participants to less than one hour of physical activity per week prior to the start of the trial, while 
Schmitz et al38 limited participants to less than two hours per week. Physical activity levels prior to 
investigation were not limited by Pasagian-Macaulay et al18 or Bentz et al.34 Moreover, some studies 
used precise measures of physical fitness level at baseline such as VO2max,2,30 or heart rate,38 while 
others relied on self-reports of physical activity,33 and still others did not address this possible 
confounding factor.18,34  
 Another baseline physical characteristic that turned out to be valuable in the post-intervention 
calculations that was not standardized was body composition. Each study used varying measures of 
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body composition that are limited by precision and accuracy. Pasagian-Macaulay et al18 and Bentz et 
al34 only measured BMI at baseline. Campbell et al, 200730 associated BMI and waist-to-hip ratio with 
body composition, while the earlier investigation authored by Campbell et al, 20052 used the sum of 
skin folds as a measure of body composition. Finally, Westerlind et al33 used the highly specific 
hydrostatic weighing technique to measure body composition, and Schmitz et al38 used another highly 
specific measure of body composition, x-ray absoptiometry. Generalizations based on these various 
measures of body composition need to be assessed with caution, as the measurements have varying 
degrees of precision.  
 
Variations in Intervention 
 There were differences among studies not only in intervention length, but in whether the 
intervention was supervised, workouts were standardized or individualized, if the exercise was self-
reported, and if the intervention was prospective or retrospective. Bentz et al34 conducted a prospective 
intervention that was two weeks in duration,  while Campbell et al, 20052 ran a retrospective 
investigation spanning 12 months. The remaining prospective trials lasted in duration from 12 weeks,30 
to 20 weeks.18  Workouts were fully supervised in the studies conducted by Campbell et al, 200730 and 
Westerlind et al,33 partially supervised in the investigation by Schmitz et al,38 and self-reported in the 
studies by Pasagian-Macaulay et al,18 Bentz et al,34 and Campbell et al, 2005.2  
 
Standardization of Samples 
 The estrogen metabolite ratios in all studies included in this review were measured with the 
newer solid-phase enzyme immunoassay. All studies measured estrogen metabolite concentrations in 
urine samples that were self-collected by the participants and brought in to the laboratory within a 
certain amount of time. All investigations used preservatives to maintain the active estrogen 
metabolites. The similarities between studies end there. Some samples were taken during the luteal 
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phase,30,34,2 some during the follicular phase,33,38 and some were not standardized to menstrual phase18. 
Some studies stratified estrogen concentrations to creatinine concentrations for better accuracy,33,34,38 
while others failed to do so.2,18,30  
 The urine samples obtained in the study conducted by Pasagian-Macaulay et al18 were not 
standardized to menstrual phase at all. Schmitz et al38 collected urine samples during the self-reported 
follicular phase, while Bentz et al34 collected urine samples during the self-reported luteal phase. The 
recent investigation of Campbell et al, 200730 measured luteal phase urine samples, verified by salivary 
hormone levels, while the previous study by Campbell, 20052 measured both luteal and follicular urine 
samples, also verified by salivary hormone measurements.  Finally, Westerlind et al33 measured both 
follicular and luteal hormone levels and verified menstrual phase by daily urine hormone level 
concentrations. Varying results were found between the luteal and follicular phases, with higher 
absolute concentrations in the luteal phase. Therefore, samples not standardized to luteal phase of the 
menstrual cycle may not be an accurate measure of hormone concentrations.  
 
Sample Size and Dropout Rate 
 Many of the investigations included in this review were limited by small sample size, high 
dropout rate, or both. The largest investigation was conducted by Pasagian-Macaulay et al18, and 
included 84 participants in the intervention group and 90 in the control group.  Bentz et al34 also had a 
larger population in comparison, with 77 total participants. Dropout rate was not addressed by either 
study. Schmitz et al38 experienced the highest dropout rate over the course of their investigation. Only 
15 out of 28 total participants completed the study, which is a 54% dropout rate.38 In the latest 
investigation by Campbell et al, 200730 14 out of the original 17 completed at least 80% of the 
intervention workouts, and 15 out of 15 participants assigned to the control group completed the study. 
Twenty-four of the original 31 participants in the study by Westerlind et al33 completed the trial.  
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Finally, in the earlier investigation lead by Campbell et al, 2005,2 17 out of 18 in the high fitness group 
completed the investigation, while 13 out of 18 in the average fitness group completed the study.  
 
Aerobic Fitness Measurements 
 The measures of physical fitness from baseline to the conclusion of the study differed among 
authors. This variation might lead readers to conclude that increases in physical fitness reported by the 
study might not be accurate. Physical fitness was not measured at the start or conclusion of the trial led 
by Bentz et al,34 while it was only measured at baseline in the studies by Schmitz et al38 and Campbell 
et al, 2005.2  Variations in baseline measurements discussed above might also affect the results of these 
investigations. Physical fitness was measured only by change in weight and BMI by Pasagian-
Macaulay et al,18 while it was measured with standardized VO2max scores in the studies conducted by 
Campbell et al, 200730 and Westerlind et al.33  
 
Race 
 The final variation among these investigations that might affect the results of the studies and 
the ability of the reader to generalize these results is the selection of participants based on race. Some 
investigators limited their study populations to Caucasian females only,2,30 while others did not limit 
their study participants based on race at all.18,33,38  Bentz et al34 specifically excluded African American 
participants based on the prevalence for a genetic mutation in estrogen metabolism.  If this genetic 
predisposition is verified by scientific investigation and prevalent in African American populations 
alone, then the inclusion of this population subgroup in other studies included in this review might 
affect their results.  
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Suggestions for Future Areas of Research 
The authors of these six studies suggested many different avenues for potential future research, 
many of these suggestions based on limitations in their own investigations. One common agreement 
for an area of future research is to conduct further large, randomized controlled trials,38 with both short 
and long interventions on both diet and exercise,18 using objective measurements of physical activity 
recording that can easily be duplicated.2,30,34  
Other suggestions for areas of further investigation were the relationship between body 
composition and 2:16 ratio,30,2 the relationship between physical activity and other estrogen 
metabolites,30,38 and the effects of physical activity during other life stages.18,30  Based on their results, 
Westerlind et al33 suggested future research to concentrate on the baseline 2:16 measurements and the 
association with change in that ratio across intervention.  Because Schmitz et al38 recorded the most 
statistical significance with results gathered during the luteal phase, the authors suggested future 
research should concentrate on the luteal phase in the menstrual cycle as the point when potential 
changes in estrogen metabolism can be best identified.  
  
CONCLUSION 
 The results of these six investigations demonstrate that although there is an established breast 
cancer risk reduction for young women who are physically active, this risk reduction might not be 
achieved through the estrogen metabolism pathway. However, due to small sample sizes and lack of 
control groups or menstrual cycle standardization in many studies, it is nearly impossible to be able to 
generalize the results found in the studies to a larger population of women. There is potential that the 
effect physical activity has on estrogen metabolism was simply not great enough in the studies to be 
statistically significant due to variations in absolute hormone levels during menstrual cycles, or due to 
small sample sizes that did not present enough variety in baseline estrogen metabolite ratios.  
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 Future research is needed first and foremost to determine if there is indeed an association 
between breast cancer risk reduction and physical activity related to the change in estrogen metabolite 
ratio to favor the anti-estrogenic metabolite 2-hydoxyestrone. To accomplish this, there needs to be a 
number of randomized controlled trials that investigate the relationship of absolute concentrations of 2-
hydroxyestrone and 16α-hydroxyestrone, along with the ratio between the two metabolites. There are 
several criteria that a future endeavor would need to meet in order to be more precise in treatment 
effect and therefore results would be able to be generalized to a larger female population.  
The estrogen metabolite concentrations that will be calculated from urine samples need to be 
stratified to creatinine levels in urine to get an absolute concentration rather than a relative 
concentration. The samples need to be standardized in their collection, preferably during the luteal 
phase of the menstrual cycle, when the metabolites are all at their peak concentrations. If possible, 
menstrual phase should be verified by measuring hormone levels, as many women have differing cycle 
lengths. The method of collection of urine samples should be streamlined, and if possible, samples 
should be taken in a laboratory facility, where temperature and time from sample collection to 
processing can be standardized.  
 This ideal randomized controlled trial would have a population that included all ages, races, 
levels of body composition, and levels of baseline physical activity. Ideally, the population studied 
would be large enough to be generalized to the greater population of females. There would also need to 
be a control group of participants with the same baseline characteristics, who undergo some sort of 
placebo intervention simultaneously. The physical activity should be standardized and supervised 
among participants, using objective measures of physical fitness and exertion. Other factors affecting 
breast cancer risk, such as obesity, diet, and family history would need to be well controlled for. The 
Physical Activity for Total Health (PATH) Study, designed to measure many of these criteria, is 
currently underway.20  Perhaps results from this investigation will shed new light on the relationship 
between physical activity and estrogen metabolism.  
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Other areas of future research need to concentrate on differing hypotheses about the potential 
causes of this association between exercise and reduction in breast cancer risk. There is a possibility 
that the risk reduction found in women who regularly exercise is limited to postmenopausal women.20 
The change in estrogen metabolism that occurs during menopause favors the more estrogenic 16α-
hydroxyestrone metabolite, which in turn decreases the 2:16 metabolite ratio.40 As Westerlind et al 
discovered,33 the baseline ratios of 2:16 estrogen metabolism were inversely correlated with percent 
change in ratio during intervention. Since postmenopausal women have a lower baseline ratio than 
premenopausal women, perhaps this association is better seen in postmenopausal women. 
Nevertheless, studies have shown a decrease in breast cancer risk in premenopausal women who are 
physically active,4,6 so more research is needed to determine the cause of this phenomenon.  
Sex steroid concentrations, circulating growth factors and binding proteins are other areas that 
call for further investigation. There is evidence that these factors also affect breast cancer risk,27,31 and 
future studies should concentrate on all potential factors with a controlled exercise intervention to 
determine which factor might potentially have the greatest effect on breast cancer risk.  
Other potential causes for the change in estrogen metabolite ratio include body weight, BMI, 
body fat percentage, and lean body mass.23,42  It is possible that the change in estrogen metabolism 
associated with reduced breast cancer risk is more related to body composition than to physical activity 
that changes body composition. Perhaps statistically significant changes were not found in these six 
interventions because there was not enough physical activity to produce the changes in body 
composition necessary to change the estrogen metabolite profile.37 Previous studies show a greater 
breast cancer risk reduction in individuals who are active across their lifetime.8,9,14,43 If this is the case, 
then physical activity, along with diet and lifestyle changes, might only be the method of achieving 
body composition changes that reduce breast cancer risk.  
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TABLES 
 
Table 1: Summary of Results of Selected Studies 
Study Yr. Patients/  
Population 
Intervention Comparison Outcome Study 
type 
Validity 
Score 
Campbell et al  
200730 
2007 Premenopausal 
females (see Table 2) 
17 participants 
12 weeks 3-4d/wk 
measured by VO2 max 
15 participants 
Maintained normal 
activity 
No change in 2/16 ratio 
in either group 
 
RCT 8 
Pasagian- 
Macaulay et al18 
1996 Premenopausal 
females (see Table 2) 
84 participants 
20 week intervention 
5-15lb wt loss, reduce total 
fat, CHD, increase PA 
20% of calories 
90 participants 
Maintained normal 
activity level 
Increased 2/16 ratio in 
both groups, no 
significant difference 
between groups 
 
RCT 8 
Westerlind et al33 2007 Premenopausal 
females (see Table 2) 
31 participants 
4 month intervention 
exercise combined with 
calorie restriction 
All participants 
were compared to 
baseline measures 
of same  
No statistically significant 
change in 2/16 ratio, but 
the lowest baseline 2/16  
had the greatest change 
Crossover 6 
Schmitz et al38 2008 Premenopausal 
females (see Table 2) 
15 total participants 
Exercise 5x/wk x12 weeks 
Baseline 
measurements of 
same participants  
No change in 2/16 ratio 
from baseline 
 
Crossover 6 
Bentz et al34 2005 Premenopausal 
females (see Table 2) 
77 Participants 
 
Compared BMI, MET 
hrs/day, age,  
Stratified into 
quadrants based on 
level of physical 
activity 
Increased 2:16 ratio with 
increased physical activity 
BMI not reliable for 
athletes in study 
Crossover 5 
Campbell et al 
20052 
2005 Premenopausal 
females (see Table 2) 
17 women 
Reported physical activity 
3-5x/wk(368min/wk ave) 
Compared diet and PA 
13 women 
Little or no 
exercise (average 
64min/wk) 
No change in 2:16 ratio 
between groups 
Increased 2:16 ratio and 
skin folds, BMI 
Cohort 4 
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Table 2: Inclusion and Exclusion Criteria of Included Articles 
 
Study Physical 
Activity 
Age BMI Regular 
Menses 
Hormonal 
Contraceptives 
Tobacco Medical 
conditions 
Antidepressants 
or Antibiotics 
Physical 
Limitations 
Intact 
ovaries 
and 
uterus 
Other Criteria 
Campbell 
et al 200730 
<20min/ 
day, 
3x/week 
 
20-
35 
18-
29.9 
24-36 day 
cycle, 
10/12months 
None x6 months None x12 
months 
None None None ___ Caucasian, VO2 
Max <40 mL/kg/ 
min, not vegetarian 
Pasagian-
Macaulay 
et al18 
___ 44-
50 
20-
34 
10/12 
months 
None ___ None ___ ___ Yes <5 alcoholic 
beverages/ day, no 
psychiatric 
hospitalizations 
Westerlind 
et al33 
<1hours/ 
week 
25-
40 
18-
35 
Self-reported None x6 months None None None None ___ GYN age >13 yrs 
Schmitz et 
al38 
<2x/ 
week 
x6month 
18-
25 
18-
40 
25-32 days None x1 year None x1 
month 
None ___ None Yes <7 alcoholic 
beverages/ week, 
not pregnant, 
nulliparous, no 
GYN disorders 
Bentz et 
al34 
__ __ 18-
30 
26-32 days None x3 months None x6 
months 
None ___ ___ ___ Caucasian, not 
vegetarian, not 
pregnant 
Campbell 
et al 20052 
___ 20-
42 
18-
24 
24-36 days, 
10/12months 
None x6 months None x12 
months 
None None None ___ Caucasian, not 
vegetarian  
Items left blank were not addressed by the study. Medical Conditions included diabetes, thyroid disorders, liver or kidney disorders, or uncontrolled hypertension.  
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Table 3: Limitations of Selected studies 
Study Baseline 
characteristics 
Type 
of 
Study 
Intervention Menstrual 
Cycle 
Metabolite 
Levels 
Additional 
Diet 
Changes 
Sample size 
& Dropout 
Rate 
Control 
Group  
Fitness 
Measure-
ments 
Race 
Campbell 
et al 
200730 
Ratio: Not measured 
PA: <20min/ day, 
3x/wk, VO2max <40 
Body comp: BMI and 
WHR 
RCT Length: 12 
weeks 
Supervised: 
Yes 
Prospective: 
Yes 
Luteal 
phase, 
verified with 
saliva 
hormone 
levels 
Not stratified 
to creatinine 
concentration 
No diet 
changes. 
Intervention: 
14/17 
completed 
80% 
Control: 
15/15 
completed  
No similar 
intervention 
for control 
group 
VO2max Caucasian 
females 
only 
Pasagian-
Macaulay 
et al18 
Ratio: Measured 
PA: No limitations 
Body comp: BMI only  
RCT Length: 20 
weeks 
Supervised: 
Self-reported 
Prospective: 
Yes 
Not 
standardized 
Not stratified 
to creatinine 
concentration 
Additional 
dietary 
intervention 
Intervention: 
84 
Control: 90 
Dropout 
rate not 
discussed 
No similar 
intervention 
for control 
group 
Measured by 
weight and 
BMI change 
No 
criteria 
set 
Westerlind 
et al33 
Ratio: Not meausred 
PA: <1hr/wk 
Body comp: Measured 
with hydrostatic 
weighing 
Cross
-over 
Length: 16 
weeks 
Supervised: 
Yes 
Prospective: 
Yes 
Folicular and 
luteal phases, 
verified with 
daily urine 
hormone 
levels 
Stratified to 
creatinine 
concentration 
Additional 
dietary 
intervention 
24/31 
completed 
study 
No control 
group 
VO2max No 
criteria 
set 
Schmitz et 
al38 
Ratio: Not meausred 
PA: <2hrs/wk, fitness 
assessed by HR 
Body comp: Measured 
x-ray absorptiometry 
Cross
-over 
Length: 15 
weeks 
Supervised: 
Partially 
Prospective: 
Yes 
Self-
reported 
follicular 
phase 
Stratified to 
creatinine 
concentration 
No diet 
changes 
15/28 
completed 
study 
No control 
group 
Not 
measured, but 
also recorded 
lipid 
peroxidation 
markers 
No 
criteria 
set 
Bentz et 
al34 
Ratio: Not measured 
PA: No limitations 
Body comp: BMI only 
Cross
-over 
Length: 2 weeks 
Supervised: 
Self-reported 
Prospective: 
Yes 
Self-
reported 
luteal phase 
Stratified to 
creatinine 
concentration 
Self-
reported 
dietary logs 
recorded 
77 women 
all 
completed 
study 
No control 
group 
Not measured African 
American 
women 
excluded 
Campbell 
et al2 
Ratio: Not measured 
PA: Either no PA or 
>3-5 days/wk, VO2max 
either >48 or <40 
Body comp: Sum of 
skin folds only 
Co-
hort 
Length: 12 
months 
Supervised: 
Self-reported 
Prospective: 
Retrospective 
Luteal and 
follicular 
phases, 
verified with 
salivary 
hormone 
levels 
Not stratified 
to creatinine 
concentration 
Self-
reported 
dietary logs 
recorded 
High fitness 
group: 17/18 
completed 
Average 
fitness group: 
13/18 
completed 
No control 
group 
Not measured Caucasian 
only 
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Table 4: Validity Scoring of Selected Studies 
 
 Study Score 
Validity Measure Campbell 
et al 200730 
Pasagian-
Macaulay et al18 
Westerlind 
et al33 
Schmitz 
et al38 
Bentz 
et al34 
Campbell et 
al 20052 
Were the inclusion and exclusion criteria well specified? 1 1 1 1 1 1 
Was there a comparison/control group? 
If so, were groups similar at start of trial? 
1 1 0 0 0 0 
Were the two groups randomly assigned by a valid method of 
randomization? 
1 1 0 0 0 0 
Was exercise the only intervention? 1 0 0 1 0 0 
Was there a similar intervention for the control group? 0 0 0 0 0 0 
Were the participants’ workouts supervised as opposed to self-
reported? 
1 1 1 1 0 0 
Were the sample sizes greater than 30? 0 1 1 0 1 0 
Were all patients who entered the trial properly accounted for 
and attributed at its conclusion? Were these patients included in 
the final calculations? 
1 1 1 1 1 1 
Were the results measured in change in 2/16 ratio? 1 1 1 1 1 1 
Are the likely benefits worth the potential harms and costs? 1 1 1 1 1 1 
TOTAL SCORE 8 8 6 6 5 4 
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